Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial.
Martin Alan MenterStanley CohenJonathan KayVibeke StrandAlice GottliebStephen HanauerSravan Kumar EduruSusanne BuschkeBenjamin LangKarl-Heinz LiesenfeldJennifer SchaibleDorothy McCabePublished in: American journal of clinical dermatology (2022)
ClinicalTrials.gov: NCT03210259 (registered July 2017); Eudract.ema.europa.eu: 2016-002254-20.